PhaseBio Pharmaceuticals: Q1 Earnings Insights

 

PhaseBio Pharmaceuticals PHAS reported its Q1 earnings results on Monday, May 16, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.

Earnings

PhaseBio Pharmaceuticals beat estimated earnings by 65.15%, reporting an EPS of $-0.23 versus an estimate of $-0.66.

Revenue was up $117.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.31 which was followed by a 5.0% drop in the share price the next day.

Here's a look at PhaseBio Pharmaceuticals's past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.59 -0.61 -0.48 -0.69
EPS Actual -0.90 -0.66 -0.60 -0.87
Revenue Estimate 1.97M 1.07M 4.02M 30.00K
Revenue Actual 158.00K 335.00K 10.34M 0

To track all earnings releases for PhaseBio Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!